Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24034379.
- Also identified by DOI 10.1016/j.jaad.2013.07.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kawasaki disease, or mucocutaneous lymph node syndrome, most commonly affects children between 6 months and 5 years of age. Approximately 90% of patients have mucocutaneous manifestations. This article will focus on the epidemiology of Kawasaki disease in the United States as it relates to other countries, the diagnosis of Kawasaki disease, its clinical course, and the currently accepted theories of pathogenesis. A particular focus is given to the various dermatologic manifestations that may occur.
Medical subject headings
- Cardiovascular Diseases
- Immunoglobulins, Intravenous
- Mucocutaneous Lymph Node Syndrome